SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Keller SD, Majkut TC, Kosinski M, Ware JE. Monitoring health outcomes among patients with arthritis using the SF-36 health survey. Med Care 1999; 37: MS19.
  • 2
    Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 13745.
  • 3
    Cella D, Hahn EA, Dineen K. Meaningful change in cancer-specific quality of life scores: differences between improvement and worsening. Qual Life Res 2002; 11: 20721.
  • 4
    Dickens C, McGowan L, Clark-Carter D, Creed F. Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis. Psychosom Med 2002; 64: 5260.
  • 5
    Allaire SH. Update on work disability in rheumatic diseases. Curr Opin Rheumatol 2001; 13: 938.
  • 6
    Soderlin MK, Hakala M, Nieminen P. Anxiety and depression in a community-based rheumatoid arthritis population. Scand J Rheumatol 2000; 29: 17783.
  • 7
    Meenan RF, Gertman PM, Mason JH. Measuring health status in arthritis: the Arthritis Impact Measurement Scales. Arthritis Rheum 1980; 23: 14652.
  • 8
    Mason JH, Anderson JJ, Meenan RF, Haralson KM, Lewis-Stevens D, Kaine JL. The Rapid Assessment of Disease Activity in Rheumatology (RADAR) questionnaire. Arthritis Rheum 1992; 35: 15662.
  • 9
    Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1998; 280: 19923.
  • 10
    Keller SD, Ware JE, Hatoum HT, Kong SX. The SF-36 Arthritis-Specific Health Index (ASHI): II. Tests of validity in four clinical trials. Med Care 1999; 37 Suppl 5: MS5160.
  • 11
    Ware JE, Keller SD, Hatoum HT, Kong SX. The SF-36 Arthritis-Specific Health Index (ASHI): I. Development and cross-validation of scoring algorithms. Med Care 1999; 37 Suppl 5: MS4050.
  • 12
    Kosinski M, Keller SD, Hatoum HT, Kong SX, Ware JE. The SF-36 health survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: tests of data quality, scaling assumptions, and score reliability. Med Care 1999; 37 Suppl 5: MS1022.
  • 13
    Kosinski M, Keller SD, Ware JE, Hatoum HT, Kong SX. The SF-36 health survey as a generic outcome measure in clinical trials of patients with osteoarthritis and rheumatoid arthritis: relative validity of scales in relation to clinical measures of arthritis severity. Med Care 1999; 37 Suppl 5: MS2339.
  • 14
    Kaplan RM, Schmidt SM, Cronan TA. Quality of well being in patients with fibromyalgia. J Rheumatol 2000; 27: 7859.
  • 15
    Lenert L, Kaplan RM. Validity and interpretation of preference-based measures of health-related quality of life. Med Care 2000; 38 Suppl 9: II13850.
  • 16
    Kaplan RM, Anderson JP. The General Health Policy Model: an integrated approach. In: Spilker B, editor. Quality of life and pharmacoeconomics in clinical trials. Philadelphia: Lippincott-Raven; 1996. p. 30922.
  • 17
    Kaplan RM, Sieber WJ, Ganiats TG. The Quality of Well-Being Scale: comparison of the interviewer-administered version with a self-administered questionnaire. Psychol Health 1997; 12: 78391.
  • 18
    Kelsey JL, White AA 3rd, Pastides H, Bisbee GE Jr. The impact of musculoskeletal disorders on the population of the United States. J Bone Joint Surg Am 1979; 61: 95964.
  • 19
    Coons SJ, Kaplan RM. Quality of life assessment: understanding its use as an outcome measure. Hosp Formul 1993; 28: 48690, 92, 97–8.